News
In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...
In the wake of Robert F. Kennedy Jr.’s abrupt revamp of the CDC’s Advisory Committee on Immunization Practices, details from ...
Antibody-drug conjugates, or ADCs, are still holding on to their spot as one of the hottest areas in cancer care—and AbbVie, ...
AstraZeneca has penned a drug discovery pact focused on chronic diseases with China's CSPC Pharma. The FDA has halted new trials that export U.S. individuals' living cells to China. | AstraZeneca has ...
With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...
The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...
The Trump administration is weighing measures that would make it more expensive for pharmaceutical companies to conduct ...
The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend ...
June, advertising agencies that work behind the scenes to execute drug ads are rewarded with their moment in the spotlight as ...
It’s been years since the Cannes Lions International Festival of Creativity awarded its top prize to a traditional ...
Secretary Robert F. | Following HHS secretary Robert F. Kennedy Jr.’s decision last week to purge the CDC’s Advisory ...
Trump has threatened that pharmaceutical import tariffs could clock in at “25% or higher.” The President first floated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results